TUMOR SUPPRESSOR RARRES1/TIG1 IN PROSTATE CANCER BIOMARKERS TO THERAPRUTIC TARGET

$1,094,672FY2012Department of DefenseDOD

University Of The District Of Columbia, Washington DC

Investigators